KZR DEF 14A DEF-14A Report April 26, 2024 | Alphaminr
Kezar Life Sciences, Inc.

KZR DEF 14A Report ended April 26, 2024

KEZAR LIFE SCIENCES, INC.
CIK: 1645666
Filing Type: DEFA14A
Report Date: 2024-04-26
Download URL: https://www.sec.gov/Archives/edgar/data/1645666/000095017024049121/kzr-20240426.htm
]]>
TABLE OF CONTENTS
QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTINGPROPOSAL 1 ELECTION OF DIRECTORSGeneralVote RequiredOur RecommendationInformation About Our Continuing DirectorsINFORMATION REGARDING THE BOARD AND CORPORATE GOVERNANCEBoard Diversity MatrixBoard IndependenceLeadership Structure and Risk OversightBoard Meetings and AttendanceBoard CommitteesAudit Committee ReportCode of Business Conduct and EthicsCorporate Governance GuidelinesHedging PolicyPROPOSAL 2 ADVISORY VOTE ON EXECUTIVE COMPENSATIONVote RequiredOur RecommendationPROPOSAL 3 ADVISORY VOTE ON FREQUENCY OF SOLICITATION OF ADVISORY STOCKHOLDER APPROVAL OF EXECUTIVE COMPENSATIONVote RequiredOur RecommendationPROPOSAL 4 RATIFICATION OF THE SELECTION OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMVote RequiredIndependent Registered Public Accounting Firm FeesPre-Approval Policies and ProceduresOur RecommendationPROPOSAL 5 APPROVAL OF REVERSE STOCK SPLITVote RequiredOur RecommendationEXECUTIVE OFFICERSEXECUTIVE OFFICER AND DIRECTOR COMPENSATIONExecutive Officer CompensationDirector CompensationPAY VERSUS PERFORMANCEEQUITY COMPENSATION PLAN INFORMATIONTRANSACTIONS WITH RELATED PERSONS AND INDEMNIFICATIONPolicies and Procedures Regarding Transactions with Related PersonsCertain Related-Party TransactionsIndemnificationSECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENTOTHER INFORMATION FOR STOCKHOLDERSOTHER MATTERSAPPENDIX ACertificate of Amendment to the Amended and Restated Certificate of Incorporation of Kezar Life Sciences, Inc.